Glycemic Status and Infection Risk in Nondiabetic Autologous Hematopoietic Cell Transplantation Recipients

Marilyn Hammer, Gail D'Eramo Melkus, M. Tish Knobf, Corey Casper, Jason Fletcher, Charles M. Cleland

Research output: Contribution to journalArticle

Abstract

Background: Patients undergoing hematopoietic cell transplantation (HCT) for hematological malignancies experience a number of challenges during treatment. There is growing evidence that malglycemia (hyperglycemia, hypoglycemia, and/or increased glycemic variability) contributes to HCT-related complications, even in patients without preexisting diabetes. The purpose of this pilot study was to investigate factors influencing glycemic status and associated infection occurrences in nondiabetic autologous HCT recipients. Methods: Oncology patients without preexisting diabetes treated with autologous HCT at a National Cancer Institute–designated cancer center were followed from admission through discharge or 28 days post-HCT. Patients had morning fasting laboratory tests. Descriptive statistics and Cox proportional hazards models were used to examine associations between BG levels and risk for infection while adjusting for baseline covariates including age, body mass index (BMI), cumulative glucocorticoid dose, and diagnosis. Results: The sample included 28 female and 25 male predominately non-Hispanic White patients (mean age 55.7 years, SD = 11.32). Blood glucose (BG) range was 35–325 mg/dl. Twenty-three patients incurred at least one infection. BMI ≥ 25 kg/m2 was associated with high BG and infections. In the multivariate Cox model, an increase of 1 interquartile range in BG 2 days before infection was associated with a moderately increased risk of infection (hazard ratio = 1.44, p =.008). Conclusions: Understanding the contributors to and consequences of malglycemic events can lead to better protocols for identifying patients at greater risk for infection. Further investigation is warranted for interventions to mitigate BG events for improved outcomes.

Original languageEnglish (US)
Pages (from-to)344-350
Number of pages7
JournalBiological Research for Nursing
Volume18
Issue number3
DOIs
StatePublished - 2015

Fingerprint

Cell Transplantation
Blood Glucose
Infection
Proportional Hazards Models
Body Mass Index
Hematologic Neoplasms
Hypoglycemia
Hyperglycemia
Glucocorticoids
Fasting
Neoplasms

Keywords

  • autologous hematopoietic cell transplantation
  • glycemic status
  • infections

ASJC Scopus subject areas

  • Research and Theory

Cite this

Glycemic Status and Infection Risk in Nondiabetic Autologous Hematopoietic Cell Transplantation Recipients. / Hammer, Marilyn; D'Eramo Melkus, Gail; Knobf, M. Tish; Casper, Corey; Fletcher, Jason; Cleland, Charles M.

In: Biological Research for Nursing, Vol. 18, No. 3, 2015, p. 344-350.

Research output: Contribution to journalArticle

Hammer, Marilyn ; D'Eramo Melkus, Gail ; Knobf, M. Tish ; Casper, Corey ; Fletcher, Jason ; Cleland, Charles M. / Glycemic Status and Infection Risk in Nondiabetic Autologous Hematopoietic Cell Transplantation Recipients. In: Biological Research for Nursing. 2015 ; Vol. 18, No. 3. pp. 344-350.
@article{20d6eaf5518045b0ba326ff3a1764334,
title = "Glycemic Status and Infection Risk in Nondiabetic Autologous Hematopoietic Cell Transplantation Recipients",
abstract = "Background: Patients undergoing hematopoietic cell transplantation (HCT) for hematological malignancies experience a number of challenges during treatment. There is growing evidence that malglycemia (hyperglycemia, hypoglycemia, and/or increased glycemic variability) contributes to HCT-related complications, even in patients without preexisting diabetes. The purpose of this pilot study was to investigate factors influencing glycemic status and associated infection occurrences in nondiabetic autologous HCT recipients. Methods: Oncology patients without preexisting diabetes treated with autologous HCT at a National Cancer Institute–designated cancer center were followed from admission through discharge or 28 days post-HCT. Patients had morning fasting laboratory tests. Descriptive statistics and Cox proportional hazards models were used to examine associations between BG levels and risk for infection while adjusting for baseline covariates including age, body mass index (BMI), cumulative glucocorticoid dose, and diagnosis. Results: The sample included 28 female and 25 male predominately non-Hispanic White patients (mean age 55.7 years, SD = 11.32). Blood glucose (BG) range was 35–325 mg/dl. Twenty-three patients incurred at least one infection. BMI ≥ 25 kg/m2 was associated with high BG and infections. In the multivariate Cox model, an increase of 1 interquartile range in BG 2 days before infection was associated with a moderately increased risk of infection (hazard ratio = 1.44, p =.008). Conclusions: Understanding the contributors to and consequences of malglycemic events can lead to better protocols for identifying patients at greater risk for infection. Further investigation is warranted for interventions to mitigate BG events for improved outcomes.",
keywords = "autologous hematopoietic cell transplantation, glycemic status, infections",
author = "Marilyn Hammer and {D'Eramo Melkus}, Gail and Knobf, {M. Tish} and Corey Casper and Jason Fletcher and Cleland, {Charles M.}",
year = "2015",
doi = "10.1177/1099800415619227",
language = "English (US)",
volume = "18",
pages = "344--350",
journal = "Biological Research for Nursing",
issn = "1099-8004",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Glycemic Status and Infection Risk in Nondiabetic Autologous Hematopoietic Cell Transplantation Recipients

AU - Hammer, Marilyn

AU - D'Eramo Melkus, Gail

AU - Knobf, M. Tish

AU - Casper, Corey

AU - Fletcher, Jason

AU - Cleland, Charles M.

PY - 2015

Y1 - 2015

N2 - Background: Patients undergoing hematopoietic cell transplantation (HCT) for hematological malignancies experience a number of challenges during treatment. There is growing evidence that malglycemia (hyperglycemia, hypoglycemia, and/or increased glycemic variability) contributes to HCT-related complications, even in patients without preexisting diabetes. The purpose of this pilot study was to investigate factors influencing glycemic status and associated infection occurrences in nondiabetic autologous HCT recipients. Methods: Oncology patients without preexisting diabetes treated with autologous HCT at a National Cancer Institute–designated cancer center were followed from admission through discharge or 28 days post-HCT. Patients had morning fasting laboratory tests. Descriptive statistics and Cox proportional hazards models were used to examine associations between BG levels and risk for infection while adjusting for baseline covariates including age, body mass index (BMI), cumulative glucocorticoid dose, and diagnosis. Results: The sample included 28 female and 25 male predominately non-Hispanic White patients (mean age 55.7 years, SD = 11.32). Blood glucose (BG) range was 35–325 mg/dl. Twenty-three patients incurred at least one infection. BMI ≥ 25 kg/m2 was associated with high BG and infections. In the multivariate Cox model, an increase of 1 interquartile range in BG 2 days before infection was associated with a moderately increased risk of infection (hazard ratio = 1.44, p =.008). Conclusions: Understanding the contributors to and consequences of malglycemic events can lead to better protocols for identifying patients at greater risk for infection. Further investigation is warranted for interventions to mitigate BG events for improved outcomes.

AB - Background: Patients undergoing hematopoietic cell transplantation (HCT) for hematological malignancies experience a number of challenges during treatment. There is growing evidence that malglycemia (hyperglycemia, hypoglycemia, and/or increased glycemic variability) contributes to HCT-related complications, even in patients without preexisting diabetes. The purpose of this pilot study was to investigate factors influencing glycemic status and associated infection occurrences in nondiabetic autologous HCT recipients. Methods: Oncology patients without preexisting diabetes treated with autologous HCT at a National Cancer Institute–designated cancer center were followed from admission through discharge or 28 days post-HCT. Patients had morning fasting laboratory tests. Descriptive statistics and Cox proportional hazards models were used to examine associations between BG levels and risk for infection while adjusting for baseline covariates including age, body mass index (BMI), cumulative glucocorticoid dose, and diagnosis. Results: The sample included 28 female and 25 male predominately non-Hispanic White patients (mean age 55.7 years, SD = 11.32). Blood glucose (BG) range was 35–325 mg/dl. Twenty-three patients incurred at least one infection. BMI ≥ 25 kg/m2 was associated with high BG and infections. In the multivariate Cox model, an increase of 1 interquartile range in BG 2 days before infection was associated with a moderately increased risk of infection (hazard ratio = 1.44, p =.008). Conclusions: Understanding the contributors to and consequences of malglycemic events can lead to better protocols for identifying patients at greater risk for infection. Further investigation is warranted for interventions to mitigate BG events for improved outcomes.

KW - autologous hematopoietic cell transplantation

KW - glycemic status

KW - infections

UR - http://www.scopus.com/inward/record.url?scp=84963674155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963674155&partnerID=8YFLogxK

U2 - 10.1177/1099800415619227

DO - 10.1177/1099800415619227

M3 - Article

VL - 18

SP - 344

EP - 350

JO - Biological Research for Nursing

JF - Biological Research for Nursing

SN - 1099-8004

IS - 3

ER -